These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. Buchhalter AR; Schrinel L; Eissenberg T Nicotine Tob Res; 2001 May; 3(2):111-8. PubMed ID: 11403724 [TBL] [Abstract][Full Text] [Related]
5. Cigarette brand-switching: effects on smoke exposure and smoking behavior. Zacny JP; Stitzer ML J Pharmacol Exp Ther; 1988 Aug; 246(2):619-27. PubMed ID: 3404450 [TBL] [Abstract][Full Text] [Related]
6. Placebo cigarettes in a spaced smoking paradigm. Eid NC; Fant RV; Moolchan ET; Pickworth WB Pharmacol Biochem Behav; 2005 May; 81(1):158-64. PubMed ID: 15894074 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting. Fagerström KO; Hughes JR; Callas PW Nicotine Tob Res; 2002; 4 Suppl 2():S141-5. PubMed ID: 12573175 [TBL] [Abstract][Full Text] [Related]
8. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. Zacny JP; Stitzer ML; Brown FJ; Yingling JE; Griffiths RR J Pharmacol Exp Ther; 1987 Feb; 240(2):554-64. PubMed ID: 3806411 [TBL] [Abstract][Full Text] [Related]
9. Effects of low nicotine content cigarettes on smoke intake. Rose J; Behm F Nicotine Tob Res; 2004 Apr; 6(2):309-19. PubMed ID: 15203805 [TBL] [Abstract][Full Text] [Related]
10. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. Melikian AA; Djordjevic MV; Hosey J; Zhang J; Chen S; Zang E; Muscat J; Stellman SD Nicotine Tob Res; 2007 Mar; 9(3):377-87. PubMed ID: 17365769 [TBL] [Abstract][Full Text] [Related]
11. Clinical laboratory evaluation of potential reduced exposure products for smokers. Breland AB; Kleykamp BA; Eissenberg T Nicotine Tob Res; 2006 Dec; 8(6):727-38. PubMed ID: 17132520 [TBL] [Abstract][Full Text] [Related]
12. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Williams JM; Gandhi KK; Steinberg ML; Foulds J; Ziedonis DM; Benowitz NL Nicotine Tob Res; 2007 Aug; 9(8):873-81. PubMed ID: 17654300 [TBL] [Abstract][Full Text] [Related]
14. A pilot study of nicotine delivery to smokers from a metered-dose inhaler. Caldwell B; Dickson S; Burgess C; Siebers R; Mala S; Parkes A; Crane J Nicotine Tob Res; 2009 Apr; 11(4):342-7. PubMed ID: 19346511 [TBL] [Abstract][Full Text] [Related]
15. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Strasser AA; Lerman C; Sanborn PM; Pickworth WB; Feldman EA Drug Alcohol Depend; 2007 Jan; 86(2-3):294-300. PubMed ID: 16930853 [TBL] [Abstract][Full Text] [Related]
17. Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Benowitz NL; Jacob P; Herrera B Clin Pharmacol Ther; 2006 Dec; 80(6):703-14. PubMed ID: 17178270 [TBL] [Abstract][Full Text] [Related]
18. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Strasser AA; Pickworth WB; Patterson F; Lerman C Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1800-4. PubMed ID: 15533910 [TBL] [Abstract][Full Text] [Related]
19. Large Cigars: Smoking Topography and Toxicant Exposure. Rosenberry ZR; Pickworth WB; Koszowski B Nicotine Tob Res; 2018 Jan; 20(2):183-191. PubMed ID: 27798089 [TBL] [Abstract][Full Text] [Related]
20. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Benowitz NL; Hall SM; Stewart S; Wilson M; Dempsey D; Jacob P Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2479-85. PubMed ID: 18006940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]